Ghana vs Sur: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Sur
62.0%
in 2024
Ghana rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Sur
How they compare
Ghana currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Ghana's figure about 1.6 times Sur's.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Ghana ahead.
Ghana ranks 1st and Sur ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Ghana | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 21.5% | 14.8% | Sur |
| 2010s | 75.6% | 53.0% | 22.6% | Ghana |
| 2020s | 98.6% | 78.4% | 20.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Sur?
- Ghana, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Sur?
- 38.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Sur?
- 16 years are reported by both, from 2005 to 2024.
- How do Ghana and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.